Literature DB >> 25130959

Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort.

Sarah R Gillett1, Rebekah H Boyle2, Neil A Zakai3, Leslie A McClure4, Nancy S Jenny2, Mary Cushman5.   

Abstract

OBJECTIVES: The REasons for Geographic and Racial Differences in Stroke (REGARDS) study is a prospective cohort of 30,239 Americans in the contiguous United States; the first of this scale to use home visits to obtain, process, and ship biologic samples to a core laboratory. Pre-analytical factors resulting from this study design may affect the results of some laboratory assays. We investigated the impact of REGARDS processing on a variety of analytes. DESIGN AND METHODS: In REGARDS, blood samples were processed in the field by technicians who were trained on standardized methods for phlebotomy and sample processing. Field processing included centrifugation using varying non-uniform equipment and shipping overnight on ice to the University of Vermont, where samples were re-centrifuged for 30,000 ×g-minutes and stored at -80 °C. We assessed the effects of REGARDS sample handling by processing split samples from 20 volunteers using either ideal procedures or simulated REGARDS procedures. Assays for 19 analytes for potential study in REGARDS were then run on both samples and results compared.
RESULTS: Spearman correlation coefficients for analytes measured in ideal versus REGARDS processed samples ranged from 0.11 to 1.0. Thirteen of 19 analytes were highly correlated (>0.75), but platelet proteins were more variable.
CONCLUSIONS: Simulation of non-optimal field processing and shipment to a central laboratory showed high variability in analytes released by platelets. The majority of other analytes produced valid results, but platelet contamination in REGARDS samples makes measurement of platelet proteins unadvisable in these samples. Future analytes considered by REGARDS or similar studies should undergo similar pilot testing.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Biological markers; Blood chemical analysis; Blood specimen collection; Cohort studies; Quality control

Mesh:

Year:  2014        PMID: 25130959      PMCID: PMC5038129          DOI: 10.1016/j.clinbiochem.2014.08.003

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  13 in total

1.  Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection.

Authors:  Jennifer K Pai; Gary C Curhan; Carolyn C Cannuscio; Nader Rifai; Paul M Ridker; Eric B Rimm
Journal:  Clin Chem       Date:  2002-10       Impact factor: 8.327

Review 2.  Methodological issues in epidemiologic studies using biologic markers.

Authors:  B S Hulka; B H Margolin
Journal:  Am J Epidemiol       Date:  1992-01-15       Impact factor: 4.897

Review 3.  Adiponectin and cardiovascular disease: response to therapeutic interventions.

Authors:  Seung Hwan Han; Michael J Quon; Jeong-a Kim; Kwang Kon Koh
Journal:  J Am Coll Cardiol       Date:  2007-01-19       Impact factor: 24.094

4.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

5.  Laboratory methods and quality assurance in the Cardiovascular Health Study.

Authors:  M Cushman; E S Cornell; P R Howard; E G Bovill; R P Tracy
Journal:  Clin Chem       Date:  1995-02       Impact factor: 8.327

6.  Plasminogen activator inhibitor (PAI-1) in plasma and platelets.

Authors:  N A Booth; A J Simpson; A Croll; B Bennett; I R MacGregor
Journal:  Br J Haematol       Date:  1988-11       Impact factor: 6.998

Review 7.  Platelet alpha-granules.

Authors:  P Harrison; E M Cramer
Journal:  Blood Rev       Date:  1993-03       Impact factor: 8.250

Review 8.  Biological sample collection and processing for molecular epidemiological studies.

Authors:  Nina T Holland; Martyn T Smith; Brenda Eskenazi; Maria Bastaki
Journal:  Mutat Res       Date:  2003-06       Impact factor: 2.433

Review 9.  Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Shanshan Li; Hyun Joon Shin; Eric L Ding; Rob M van Dam
Journal:  JAMA       Date:  2009-07-08       Impact factor: 56.272

10.  Within-individual stability of obesity-related biomarkers among women.

Authors:  Robert C Kaplan; Gloria Y F Ho; XiaoNan Xue; Swapnil Rajpathak; Mary Cushman; Thomas E Rohan; Howard D Strickler; Philipp E Scherer; Kathryn Anastos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06       Impact factor: 4.254

View more
  46 in total

1.  Hemostasis biomarkers and incident cognitive impairment: the REGARDS study.

Authors:  S R Gillett; L A McClure; P W Callas; E L Thacker; F W Unverzagt; V G Wadley; A J Letter; M Cushman
Journal:  J Thromb Haemost       Date:  2018-06-06       Impact factor: 5.824

2.  Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Sarah R Gillett; Evan L Thacker; Abraham J Letter; Leslie A McClure; Virginia G Wadley; Frederick W Unverzagt; Brett M Kissela; Richard E Kennedy; Stephen P Glasser; Deborah A Levine; Mary Cushman
Journal:  Clin Neuropsychol       Date:  2015-05-15       Impact factor: 3.535

3.  Inflammation and hemostasis in atrial fibrillation and coronary heart disease: The REasons for Geographic And Racial Differences in Stroke study.

Authors:  Wesley T O'Neal; Elsayed Z Soliman; George Howard; Virginia J Howard; Monika M Safford; Mary Cushman; Neil A Zakai
Journal:  Atherosclerosis       Date:  2015-09-08       Impact factor: 5.162

4.  Haemostasis biomarkers and risk of intracerebral haemorrhage in the REasons for Geographic and Racial Differences in Stroke Study.

Authors:  Neil A Zakai; Nels C Olson; Suzanne E Judd; Dawn O Kleindorfer; Brett M Kissela; George Howard; Mary Cushman
Journal:  Thromb Haemost       Date:  2017-07-06       Impact factor: 5.249

5.  Chronic Kidney Disease Awareness and Longitudinal Health Outcomes: Results from the REasons for Geographic And Racial Differences in Stroke Study.

Authors:  Sri Lekha Tummalapalli; Eric Vittinghoff; Deidra C Crews; Mary Cushman; Orlando M Gutiérrez; Suzanne E Judd; Holly J Kramer; Carmen A Peralta; Delphine S Tuot; Michael G Shlipak; Michelle M Estrella
Journal:  Am J Nephrol       Date:  2020-04-29       Impact factor: 3.754

6.  Association of stroke risk biomarkers with stroke symptoms: the Reasons for Geographic and Racial Differences in Stroke cohort.

Authors:  K K Landry; K S Alexander; N A Zakai; S E Judd; D O Kleindorfer; V J Howard; G Howard; M Cushman
Journal:  J Thromb Haemost       Date:  2016-12-09       Impact factor: 5.824

7.  Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study.

Authors:  K L Cheung; N A Zakai; P W Callas; G Howard; B K Mahmoodi; C A Peralta; S E Judd; M Kurella Tamura; M Cushman
Journal:  J Thromb Haemost       Date:  2018-08-09       Impact factor: 5.824

8.  Secondhand Smoke Exposure and Stroke: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Angela M Malek; Mary Cushman; Daniel T Lackland; George Howard; Leslie A McClure
Journal:  Am J Prev Med       Date:  2015-06-24       Impact factor: 5.043

9.  Measures of Kidney Disease and the Risk of Venous Thromboembolism in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.

Authors:  Katharine L Cheung; Neil A Zakai; Aaron R Folsom; Manjula Kurella Tamura; Carmen A Peralta; Suzanne E Judd; Peter W Callas; Mary Cushman
Journal:  Am J Kidney Dis       Date:  2017-01-23       Impact factor: 8.860

10.  Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study.

Authors:  Yulia Khodneva; Anath Shalev; Stuart J Frank; April P Carson; Monika M Safford
Journal:  Diabetes Res Clin Pract       Date:  2016-01-15       Impact factor: 5.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.